The efficacy of hypothermia combined with thrombolysis or mechanical thrombectomy on acute ischemic stroke: a systematic review and meta-analysis.

IF 2.7 3区 医学 Q2 CLINICAL NEUROLOGY
Frontiers in Neurology Pub Date : 2025-01-07 eCollection Date: 2024-01-01 DOI:10.3389/fneur.2024.1481115
Dan Wang, Dan Yan, Mingmin Yan, Hao Tian, Haiwei Jiang, Bifeng Zhu, Yu Chen, Tao Peng, Yue Wan
{"title":"The efficacy of hypothermia combined with thrombolysis or mechanical thrombectomy on acute ischemic stroke: a systematic review and meta-analysis.","authors":"Dan Wang, Dan Yan, Mingmin Yan, Hao Tian, Haiwei Jiang, Bifeng Zhu, Yu Chen, Tao Peng, Yue Wan","doi":"10.3389/fneur.2024.1481115","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Therapeutic hypothermia improves outcomes in experimental stroke models, especially after ischemia-reperfusion injury. In recent years, the safety and efficacy of hypothermia combining thrombolysis or mechanical thrombectomy have attracted widespread attention. The primary objective of the study was to evaluate the effectiveness and safety of hypothermia by combining reperfusion therapy in acute ischemic stroke patients.</p><p><strong>Methods: </strong>A systematic search was performed in PubMed, EMBASE, Cochrane Library, and the Clinical Trial Registries on articles published until May 2024. The full-text articles were thoroughly reviewed, and relevant information regarding study characteristics and outcomes was extracted. Mantel-Haenszel (M-H) random-effects model was used to calculate pooled risk ratios (RR) with 95% confidence intervals (CI). In addition, subgroup analyses were performed focusing on the different hypothermia modalities and duration.</p><p><strong>Results: </strong>After screening 2,265 articles, 10 studies were included in the present analysis with a total sample size of 785. Forest plots of clinical outcomes were as follows: modified Rankin Scale (mRS) ≤2 at 3 months (RR = 1.28, 95% CI 1.01-1.61, <i>p</i> = 0.04), mortality within 3 months (RR = 0.95, 95% CI 0.69-1.29, <i>p</i> = 0.73), total complications (RR = 1.02, 95% CI 0.89-1.16, <i>p</i> = 0.77) and pneumonia (RR = 1.35, 95% CI 0.76-2.40, <i>p</i> = 0.31). Subgroup analyses indicated a mild protective effect of selective cerebral hypothermia; however, the difference in mortality between the hypothermia and control groups was not statistically significant (RR = 0.88, 95% CI 0.57-1.35, <i>p</i> = 0.55). Patients undergoing hypothermia for 24-48 h experienced a higher rate of overall complications (RR = 1.37, 95% CI 1.01-1.86, <i>p</i> = 0.04) and pneumonia (RR = 2.84, 95% CI 1.05-7.66, <i>p</i> = 0.04).</p><p><strong>Conclusion: </strong>The preliminary evidence supports the safety and feasibility of hypothermia combined with reperfusion therapy, which should be further investigated in randomized controlled studies.</p><p><strong>Systematic review registration: </strong>https://www.crd.york.ac.uk/prospero/, identifier CRD42024556625.</p>","PeriodicalId":12575,"journal":{"name":"Frontiers in Neurology","volume":"15 ","pages":"1481115"},"PeriodicalIF":2.7000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11746097/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fneur.2024.1481115","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Therapeutic hypothermia improves outcomes in experimental stroke models, especially after ischemia-reperfusion injury. In recent years, the safety and efficacy of hypothermia combining thrombolysis or mechanical thrombectomy have attracted widespread attention. The primary objective of the study was to evaluate the effectiveness and safety of hypothermia by combining reperfusion therapy in acute ischemic stroke patients.

Methods: A systematic search was performed in PubMed, EMBASE, Cochrane Library, and the Clinical Trial Registries on articles published until May 2024. The full-text articles were thoroughly reviewed, and relevant information regarding study characteristics and outcomes was extracted. Mantel-Haenszel (M-H) random-effects model was used to calculate pooled risk ratios (RR) with 95% confidence intervals (CI). In addition, subgroup analyses were performed focusing on the different hypothermia modalities and duration.

Results: After screening 2,265 articles, 10 studies were included in the present analysis with a total sample size of 785. Forest plots of clinical outcomes were as follows: modified Rankin Scale (mRS) ≤2 at 3 months (RR = 1.28, 95% CI 1.01-1.61, p = 0.04), mortality within 3 months (RR = 0.95, 95% CI 0.69-1.29, p = 0.73), total complications (RR = 1.02, 95% CI 0.89-1.16, p = 0.77) and pneumonia (RR = 1.35, 95% CI 0.76-2.40, p = 0.31). Subgroup analyses indicated a mild protective effect of selective cerebral hypothermia; however, the difference in mortality between the hypothermia and control groups was not statistically significant (RR = 0.88, 95% CI 0.57-1.35, p = 0.55). Patients undergoing hypothermia for 24-48 h experienced a higher rate of overall complications (RR = 1.37, 95% CI 1.01-1.86, p = 0.04) and pneumonia (RR = 2.84, 95% CI 1.05-7.66, p = 0.04).

Conclusion: The preliminary evidence supports the safety and feasibility of hypothermia combined with reperfusion therapy, which should be further investigated in randomized controlled studies.

Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42024556625.

低温联合溶栓或机械取栓治疗急性缺血性卒中的疗效:一项系统综述和荟萃分析。
背景:治疗性低温可改善实验性脑卒中模型的预后,尤其是缺血再灌注损伤后。近年来,低温联合溶栓或机械取栓的安全性和有效性引起了广泛关注。本研究的主要目的是评价低温联合再灌注治疗对急性缺血性脑卒中患者的有效性和安全性。方法:系统检索PubMed、EMBASE、Cochrane Library和Clinical Trial registres中截至2024年5月发表的文章。对全文文章进行了全面的审查,并提取了有关研究特征和结果的相关信息。采用Mantel-Haenszel (M-H)随机效应模型计算合并风险比(RR),置信区间为95%。此外,亚组分析侧重于不同的低温模式和持续时间。结果:在筛选了2265篇文献后,本分析纳入了10项研究,总样本量为785。森林的临床结果如下:改良Rankin规模(夫人)≤2 3个月(RR = 1.28,95%可信区间1.01 - -1.61,p = 0.04), 3个月内死亡率(RR = 0.95,95%可信区间0.69 - -1.29,p = 0.73)、总并发症(RR = 1.02,95%可信区间0.89 - -1.16,p = 0.77)和肺炎(RR = 1.35,95%可信区间0.76 - -2.40,p = 0.31)。亚组分析显示选择性脑低温有轻度保护作用;然而,低体温组与对照组的死亡率差异无统计学意义(RR = 0.88,95% CI 0.57-1.35, p = 0.55)。患者低体温对24 - 48 h 经验更高的总体并发症(RR = 1.37,95%可信区间1.01 - -1.86,p = 0.04)和肺炎(RR = 2.84,95%可信区间1.05 - -7.66,p = 0.04)。结论:初步证据支持低温联合再灌注治疗的安全性和可行性,有待于进一步的随机对照研究。系统综述注册:https://www.crd.york.ac.uk/prospero/,标识符CRD42024556625。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Neurology
Frontiers in Neurology CLINICAL NEUROLOGYNEUROSCIENCES -NEUROSCIENCES
CiteScore
4.90
自引率
8.80%
发文量
2792
审稿时长
14 weeks
期刊介绍: The section Stroke aims to quickly and accurately publish important experimental, translational and clinical studies, and reviews that contribute to the knowledge of stroke, its causes, manifestations, diagnosis, and management.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信